PHILADELPHIA CHROMOSOME POSITIVE CML
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE CML explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE CML trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare leukemia: drug trial launches
Disease control OngoingThis study tests a daily pill called bosutinib in children with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). It includes children who are newly diagnosed or whose cancer has stopped responding to other treatments. The goal is to find the best dose and see …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 07:37 UTC
-
New drug combo aims to let CML patients stop treatment
Disease control OngoingThis study tests if a strong drug (ponatinib) given for 6 months, followed by a standard drug (imatinib), can help people with chronic myeloid leukemia reach a deep remission. The goal is to see if patients can eventually stop all medication and stay cancer-free. The trial involv…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 11, 2026 20:38 UTC